Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals

FEMS Immunology and Medical Microbiology
Marta M WroblewskaAlex Sivan

Abstract

Microbial biofilms are considered as virulence factors. During the present study, 34 clinical strains of Acinetobacter baumannii, isolated from patients hospitalized in two tertiary care hospitals, were examined for biofilm formation. These strains showed high variability in biofilm formation. Furthermore, no relation could be found between the ability of biofilm production and molecular type, carbapenem resistance, site of isolation of the clinical strains of A. baumannii and disease severity. Interestingly, in two cases an increase in biofilm formation could be detected in A. baumannii isolates cultured from the same patient upon prolonged hospitalization.

References

Oct 1, 1996·Journal of Clinical Microbiology·B EhrensteinH Grundmann
Oct 6, 2000·Annual Review of Microbiology·G O'TooleR Kolter
Mar 7, 2003·Applied and Environmental Microbiology·Larissa HendrickxStefan Wuertz
Sep 1, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F A HaddadG P Wormser
Dec 6, 2005·Research in Microbiology·Je Chul LeeLenie Dijkshoorn
Mar 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M M WroblewskaM Luczak

❮ Previous
Next ❯

Citations

May 4, 2011·The Journal of Microbiology·Christin N McQueary, Luis A Actis
Oct 5, 2010·Journal of Bacteriology·María A MussiLuis A Actis
Dec 2, 2014·Pathogens·Valentina GentilePaolo Visca
Aug 6, 2013·American Journal of Infection Control·Pauline Cordenonsi BonezMarli Matiko Anraku de Campos
Oct 7, 2011·The Journal of Hospital Infection·P EspinalJ Vila
Sep 15, 2009·The Journal of Infection·Matthieu EveillardMarie-Laure Joly-Guillou
Oct 19, 2011·IUBMB Life·Paolo ViscaKevin J Towner
Aug 11, 2011·PloS One·Luísa C S AntunesPaolo Visca
Jan 22, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Ali Mohammadi BardbariKamran Pooshang Bagheri
Sep 16, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Paweł KrzyściakJadwiga Wójkowska-Mach
Feb 11, 2014·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Maureen V BoostPauline Cho
Nov 22, 2018·Gut Pathogens·Jetnapang KongruengVaraporn Vuddhakul
May 12, 2021·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·Nandini RaveendraVijayalakshmi Subramaniam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
J Rodríguez-BañoSpanish Group for the Study of Nosocomial Infections (GEIH)
© 2022 Meta ULC. All rights reserved